| 1. |
National Research Council (1983). Risk Assessment in the Federal Government: Managing the Process, National Academy Press, Washington, DC.
|
| |
| 2. |
Costa, L. G. (1998a) Neurotoxicity testing: a discussion of in vitro alternatives. Environ. Health Perspect.
106S, 505–510.
|
| |
| 3. |
Harry, G. J., Billingsley, M., Bruinink, A., et al. (1998) In vitro techniques for the assessment of neurotoxicity. Environ. Health Perspect.
106S, 131–158.
|
| |
| 4. |
National Research Council Committee on Neurotoxicology and Models for Assessing Risk (1992) Environmental Neurotoxicology, National Academy Press, Washington, DC.
|
| |
| 5. |
US Environmental Protection Agency (1991) Pesticide Assessment Guidelines, Subdivision E. Hazard Evaluation: Human and Domestic Animals (Addendum 10: Neurotoxicity,
series 81, 82, and 83), Office of Prevention, Pesticides and Toxic Substances, Washington, DC.
|
| |
| 6. |
US Food and Drug Administration Center for Food Safety and Applied Nutrition. (1993) Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food, US Food and Drug Administration, Washington, D.C.
|
| |
| 7. |
Ehrich, M. and Veronesi, B. (1999) In vitro neurotoxicology, in Neurotoxicology (Tilson, H. A. and Harry, G. J., eds.), Taylor & Francis, Philadelphia, pp. 37–51.
|
| |
| 8. |
Flint, O. P. (1999) An introduction to the practical applications of new in vitro tests, in Neurotoxicology in Vitro (Pentreath, V. W., ed.), Taylor & Francis, Philadelphia, pp. 3–16.
|
| |
| 9. |
Dorman, D. C. (2000). An integrative approach to neurotoxicology. Toxicol. Pathol.
28, 37–42.
|
| |
| 10. |
Campbell, I. C., Fletcher, L., Grant, P. A. A., and Abdulla, E. M. (1996) Validation of in vitro tests in neurotoxicology.
ATLA
24, 339–347.
|
| |
| 11. |
Purchase, I. F. H. (1996) In vitro toxicology methods in risk assessment. ATLA
24, 325–331.
|
| |
| 12. |
Halks-Miller, M., Fedor, V., and Tyson, C. A. (1991) Overview of approaches to in vitro neurotoxicity testing. J. Am. Coll. Toxicol.
10, 727–736.
|
| |
| 13. |
Tiffany-Castiglioni, E., Ehrich, M., Dees, L., et al. (1999) Bridging the gap between in vitro and in vivo models for neurotoxicology. Toxicol. Sci.
51, 178–183.
|
| |
| 14. |
Veronesi, B., Ehrich, M., Blusztain, J. K., Oortgiesen, M., and Durham, H. (1997) Cell culture models of interspecies selectivity
to organophosphorus insecticides. Neurotoxicology
18, 283–298.
|
| |
| 15. |
Atterwill, C. K., Bruinink, A., Drejer, J., et al. (1994) In vitro neurotoxicity tests, the report and recommendations of ECVAM workshop 3. ATLA
22, 350–362.
|
| |
| 16. |
Balls, M. and Walum, E. (1999) Towards the acceptance of in vitro neurotoxicity tests, in Neurotoxicology in Vitro (Pentreath, V. W., ed.), Taylor & Francis, Philadelphia, pp. 269–283.
|
| |
| 17. |
Slikker, W. Jr., Crump, K. S., Anderson, M. E., and Bellinger, D. (1996) Biologically based, quantitative risk assessment
of neurotoxicants. Fundam. Appl. Toxicol.
229, 18–30.
|
| |
| 18. |
Costa, L. G. (1998) Biochemical and molecular neurotoxicology: relevance to biomarker development, neurotoxicity testing and
risk assessment. Toxicol. Lett.
102–103, 417–421.
|
| |
| 19. |
Forsby, A., Pilli, F., Bianchi, V., and Walum, E. (1995) Determination of critical cellular neurotoxic concentrations in human
neuroblastoma (SH-SY5Y) cell cultures. ATLA
23, 800–811.
|
| |
| 20. |
Clemedson, C., McFarlane-Abdulla, E., Andersson, M., et al. (1996) MEIC evaluation of acute systemic toxicity. Part II. In vitro results from 68 toxicity assays used to test the first 30 reference chemicals and a comparative cytotoxicity analysis. ATLA
24, 273–311.
|
| |
| 21. |
Walum, E., Forsby, A., Clemedson, C., and Ekwall, B. (1996) Dynamic qualities of validation and the evoluation of new in vitro toxicological tests. ATLA
24, 333–338.
|
| |
| 22. |
Ehrich, M. (1998) Human cells as in vitro alternatives for toxicological research and testing: neurotoxicity studies. Comments Toxicol.
6, 189–198.
|
| |
| 23. |
Dorman, D. C., Struve, M. F., and Morgan, K. T. (1993) In vitro neurotoxicity research at CIIT. CIIT Activities
13(11–12), 1–8.
|
| |
| 24. |
Ray, D. E. (1999) Toxic cell damage, in Neurotoxicology in Vitro (Pentreath, V. W., ed.), Taylor & Francis, Philadelphia, pp. 77–103.
|
| |
| 25. |
Ehrich, M., Correll, L., and Veronesi, B. (1997) Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma
cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Fundam. Appl. Toxicol.
38, 55–63.
|
| |
| 26. |
Veronesi, B. and Ehrich, M. (1993). Differential cytotoxic sensitivity in mouse and human cell lines exposed to organophosphate
insecticides. Toxicol. Appl. Pharmacol.
120, 240–246.
|
| |
| 27. |
Ehrich, M. and Correll, L. (1998). Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by
organophosphorus esters. J. Toxicol. Environ. Health
53A, 385–399.
|
| |
| 28. |
Carlson, K., Jortner, B. S., and Ehrich, M. (2000). Organophosphorus compound-induced apoptosis in SH-SY5Y human neuroblastoma
cells. Toxicol. Appl. Pharmacol. 168, 102–113.
|
| |
| 29. |
Barber, D., Correll, L., and Ehrich, M. (1999) Comparison of two in vitro activation systems for protoxicant organophosphorous esterase inhibitors. Toxicol. Sci.
47, 6–22.
|
| |
| 30. |
Golub, M. S., Han, B., and Keen, C. L. (1999). Aluminum uptake and effects on transferrin mediated iron uptake in primary
cultures of rat neurons, astrocytes and oligodendrocytes. Neurotoxicology
20, 961–970
|
| |
| 31. |
Roberts, R., Sandra, A., Siek, G. C., Lucas, J. J., and Fine, R. E. (1992). Studies of the mechanism of iron transport across
the blood-brain barrier. Ann. Neurol.
32 S, 43–50.
|
| |
| 32. |
Aschner, M. and Clarkson, T. W. (1989). Methyl mercury uptake across bovine brain capillary endothelial cells in vitro: the
role of amino acids. Pharmacol. Toxicol.
64, 293–297.
|
| |
| 33. |
Hu, H. L., Bennett, N., Lamb, J. H., Ghersi-Egea, J.F., Schlosshauer, B., and Ray, D. E. (1997). Capacity of rat brain to
metabolize m-dinitrobenzene: an in vitro study. Neurotoxicology
18, 363–370.
|
| |
| 34. |
Song, X. and Ehrich, M. (1998). Uptake and metabolism of MPTP and MPP+ in SH-SY5Y human neuroblastoma cells. In Vitro Mol. Toxicol.
11, 3–14.
|
| |
| 35. |
Corsini, G. U., Pintus, S., Bocchetta, A., Piccardi, M. P., and Del Zompo, M. (1986). A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
is formed in rat brain in vitro by type B monoamine oxidase. J. Pharmacol. Exp. Ther.
238, 648–652.
|
| |
| 36. |
Mortenson, S. R., Brimijoin, S., Hooper, M. J., and Padilla, S. (1998) Comparison of the in vitro sensitivity of rat acetylcholinesterase
to chlorpyrifosoxon: What do tissue IC50 values represent? Toxicol. Appl. Pharmacol.
148, 46–59.
|
| |
| 37. |
Clothier, R. H., Hulme, L. M., Smith, M., and Balls, M. (1987) Comparison of the in vitro cytotoxicities and acute in vivo
toxicities of 59 chemicals. Mol. Toxicol.
1, 571–577
|
| |